Marin: Eighth Participant Treated; Two More Enrolled

On April 18, 2016, the eighth participant was treated in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness in Marin, Calif. Led by Principal Investigator Phil Wolfson, M.D., with co-therapist Julane Andries, LMFT, this study is gathering preliminary data about the safety and efficacy of MDMA-assisted psychotherapy for anxiety in 18 subjects diagnosed with a life-threatening illness. The eighth participant was enrolled on April 4 (after the previous participant dropped out), and the ninth and 10th participants were enrolled on April 14. “These visions would bubble up and come to me piece by piece,” recalls study participant John Saul of Sausalito, Calif. “My heart really cracked open. It helped me overcome my fear-based defenses.” On May 3, MAPS was a proud participant in Silicon Valley Gives, an online fundraising effort led by the Silicon Valley Community Foundation with proceeds supporting this trial. Watch the video